Mã | Lợi suất đáo hạn % | Khối lượng | Giá % | Phiếu giảm giá % | Ngày đáo hạn | Giá trị dư nợ | Giá trị khuôn mặt | Giá trị mệnh giá tối thiểu | Bên phát hành |
---|---|---|---|---|---|---|---|---|---|
6.79% | 5.82 M | 66.33% | 3.18% | 2050-07-09 | 2 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
6.62% | 6.51 M | 65.66% | 3.38% | 2060-07-09 | 1 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
6.20% | 830 K | 75.05% | 3.03% | 2040-07-09 | 1.5 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.84% | 329 K | 99.50% | 5.80% | 2064-07-05 | 500 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.76% | 5.25 M | 98.75% | 5.65% | 2054-07-05 | 600 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4369980Baxalta Incorporated 5.25% 23-JUN-2045 | 5.62% | 61 K | 96.50% | 5.25% | 2045-06-23 | 500.41 M USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |
5.59% | 5.99 M | 100.56% | 5.65% | 2044-07-05 | 800 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
5.08% | 16.5 M | 101.37% | 5.30% | 2034-07-05 | 1.1 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
TTKPH4370840Baxalta Incorporated 4.0% 23-JUN-2025 | 4.99% | 485 K | 99.72% | 4.00% | 2025-06-23 | 800.17 M USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |
4.98% | 5.85 M | 88.16% | 2.05% | 2030-03-31 | 2.5 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
4.72% | 0 | 75.78% | 2.00% | 2040-07-09 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
4.58% | 2.07 M | 101.33% | 5.00% | 2028-11-26 | 1.73 B USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
UUS82481LAD1SHIRE ACQUIST.I.IE 16/26 | 4.49% | 0 | 98.15% | 3.20% | 2026-09-23 | 1.5 B USD | 1,000.00 USD | 2,000.00 USD | Shire Acquisitions Investments Ireland DAC |
3.66% | 0 | 86.78% | 1.38% | 2032-07-09 | 1 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3.31% | 0 | 98.52% | 3.00% | 2030-11-21 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
3.20% | 0 | 91.62% | 1.00% | 2029-07-09 | 850 M EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2.92% | 0 | 95.26% | 0.75% | 2027-07-09 | 750 M EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2.79% | 0 | 99.12% | 2.25% | 2026-11-21 | 1.5 B EUR | 1,000.00 EUR | 100,000.00 EUR | Takeda Pharmaceutical Co., Ltd. | |
2.71% | 0 | 116.57% | 5.00% | 2028-11-26 | 22.68 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
— | — | — | 5.00% | 2028-11-26 | 22.68 M USD | 1,000.00 USD | 200,000.00 USD | Takeda Pharmaceutical Co., Ltd. | |
SSHPG4260178Baxalta Incorporated 4.0% 23-JUN-2025 | — | — | — | 4.00% | 2025-06-23 | 303 K USD | 1,000.00 USD | 2,000.00 USD | Baxalta, Inc. |